Pharmacokinetics of quinine in African patients with acute falciparum malaria

Pharmacy World and Science

Volumn 20, Issue 3, 1998, Pages 118-122

  Babalola, Chinedum P ^a   Bolaji, Oluseye O ^a   Ogunbona, Festus A ^a   Sowunmi, Akintunde ^b   Walker, Oladapo ^b  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Acute falciparum malaria; Pharmacokinetics; Quinine

Indexed keywords

QUININE; TETRACYCLINE;

ADOLESCENT; ADULT; AFRICA; ARTICLE; CLINICAL ARTICLE; CONVALESCENCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; NIGERIA; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PLASMODIUM; PLASMODIUM FALCIPARUM; SCHOOL CHILD;

EID: 0031900235     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008699022244     Document Type: Article

References (22)

1. World Health Organisation. Weekly Epidemiological Record 1989;16:399-403.
2. Ekanem OJ. Plasmodium falciparum not responding to chloroquine in Nigeria. Trans Roy Soc Trop Med Hyg 1985;79:141.
3. Salako LA, Aderounmu AF. In vitro chloroquine and mefloquine resistant Plasmodium falciparum in Nigeria. Lancet 1987;ii:572-3.
4. World Health Organisation. Practical chemotherapy of malaria. Technical Report Series 1990, Geneva; 805p.
5. White NJ, Looareesuwan S, Warrel DA, Warrel MJ, Bunnag D, Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 1982;73:564-72.
6. Supanaranond W, Davis TME, Prukrittayakemee S, Silamut K. Disposition of oral quinine in acute falciparum malaria. Eur J Clin Pharmac 1991;40:49-52.
7. Salako LA. Quinine and Malaria: the African experience. Acta Leidensia 1987;55:167-80.
8. Salako LA, Sowunmi A, Laoye O. Evaluation of the sensitivity in vivo and in vitro of Plasmodium falciparum in malaria to quinine in an area of full sensitivity to chloroquine. Trans Roy Soc Trop Med Hyg 1988;82:366-8.
9. Pasvol G, Newton CR, Winstanley PA, Watkins WM, Peshu NM, Were JB, et al. Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. Am J Trop Med Hyg 1991;45:702-13.
10. Mansor SM, Taylor TE, McGrath CS, Edwards G, Ward SA, Wirima JJ, et al. The safety and kinetics of intramuscular quinine in Malawian children with severe falciparum malaria. Trans Roy Soc Trop Med Hyg 1991;84:482-7.
11. Couet W, Laroche R, Floch J, Istin B, Fourtillan J, Sauniere J. Pharmacokinetics of quinine and doxicycline in patients with acute falciparum malaria: A study in Africa. Ther Drug Monit 1991;13:496-501.
12. White NJ. The pharmacokinetics of quinine in malaria. Acta Leidensia 1987;55:65-76.
13. Babalola CP, Bolaji OO, Dixon PAF, Ogunbona FA. Column liquid Chromatographic analysis of quinine in human plasma, saliva and urine. J Chromatogr 1993;616:151-4.
14. Gibaldi M, Perrier D. Pharmacokinetics, 2nd edn. New York: Marcel Dekker, 1982:409-17.
15. Metzler KD, Weiner DL. PCNONLIN User's guide, Lexington. Statistical Consultants, 1982 A1-A53.
16. Jamaludin A, Mohamad M, Mavaratnam V, Selliah K, Tan SC, Wernsdorfer WH, et al. Relative bioavailability of the hydrochloride, sulphate and ethylcarbonate salts of quinine. Br J Clin Pharmacol 1988;25:261-3.
17. Merkus FW, Smit EH. The use of quinine in the treatment of malaria from the past to future. Int. Pharmacy J 1988;2:47-50.
18. Peters W. The problem of drug resistance in malaria. Parasitology 1985;90:705-715.
19. Warhurst DC. Cinchona alkaloids and malaria. Acta Leidensia 1987;55:53-64.
20. Chongsuphajaisiddhi T, Sabchareon A, Attanath P. Treatment of quinine-resistant falciparum malaria in Thai children. Southeast Asian J Trop Med Publ Hlth 1983;14:357-60.
21. Silamut K, White NJ, Looareesuwan S, Warrel DA. Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg 1985;34:681-6.
22. Silamut K, Molunto P, Ho M, Davis TM. White NJ. Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol 1991;32:311-315.